Birchview Capital as of June 30, 2021
Portfolio Holdings for Birchview Capital
Birchview Capital holds 62 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 31.8 | $53M | 796k | 66.82 | |
Accelr8 Technology | 10.7 | $18M | 2.2M | 8.04 | |
Biodesix (BDSX) | 8.7 | $15M | 1.1M | 13.21 | |
Neurocrine Biosciences (NBIX) | 4.7 | $7.8M | 80k | 97.32 | |
Quidel Corporation | 4.6 | $7.6M | 60k | 128.12 | |
ACADIA Pharmaceuticals (ACAD) | 2.9 | $4.9M | 199k | 24.39 | |
Biogen Idec (BIIB) | 2.5 | $4.2M | 12k | 346.28 | |
Albireo Pharma | 2.3 | $3.9M | 111k | 35.18 | |
Foghorn Therapeutics (FHTX) | 2.0 | $3.4M | 314k | 10.67 | |
United Therapeutics Corporation (UTHR) | 1.9 | $3.2M | 18k | 179.39 | |
Karyopharm Therapeutics (KPTI) | 1.4 | $2.4M | 230k | 10.32 | |
Bluebird Bio (BLUE) | 1.4 | $2.4M | 74k | 31.99 | |
Acceleron Pharma | 1.4 | $2.3M | 19k | 125.48 | |
Masimo Corporation (MASI) | 1.2 | $1.9M | 8.0k | 242.50 | |
Angion Biomedica Corp | 1.2 | $1.9M | 61k | 31.97 | |
Vanda Pharmaceuticals (VNDA) | 1.0 | $1.7M | 80k | 21.51 | |
Harrow Health (HROW) | 1.0 | $1.7M | 180k | 9.29 | |
Prothena Corp SHS (PRTA) | 0.9 | $1.6M | 30k | 51.41 | |
Arena Pharmaceuticals | 0.9 | $1.5M | 22k | 68.18 | |
Continental Resources | 0.9 | $1.5M | 39k | 38.03 | |
Amarin Corp Spons Adr New (AMRN) | 0.8 | $1.3M | 300k | 4.38 | |
ImmunoGen | 0.7 | $1.3M | 190k | 6.59 | |
Nektar Therapeutics (NKTR) | 0.7 | $1.2M | 72k | 17.17 | |
Alkermes SHS (ALKS) | 0.7 | $1.2M | 50k | 24.52 | |
Cullinan Oncology (CGEM) | 0.7 | $1.2M | 45k | 25.76 | |
Arvinas Ord (ARVN) | 0.7 | $1.2M | 15k | 77.00 | |
Equitrans Midstream Corp (ETRN) | 0.7 | $1.1M | 133k | 8.51 | |
Corcept Therapeutics Incorporated (CORT) | 0.7 | $1.1M | 50k | 22.00 | |
Encana Corporation (OVV) | 0.6 | $1.1M | 34k | 31.46 | |
Soleno Therapeutics | 0.6 | $1.0M | 877k | 1.14 | |
Biohaven Pharmaceutical Holding | 0.6 | $971k | 10k | 97.10 | |
Progenity | 0.6 | $964k | 270k | 3.57 | |
Kalvista Pharmaceuticals (KALV) | 0.6 | $958k | 40k | 23.95 | |
Progyny (PGNY) | 0.5 | $885k | 15k | 59.00 | |
Contrafect | 0.5 | $880k | 200k | 4.40 | |
G1 Therapeutics | 0.5 | $878k | 40k | 21.95 | |
Translate Bio | 0.5 | $826k | 30k | 27.53 | |
Inari Medical Ord (NARI) | 0.4 | $653k | 7.0k | 93.29 | |
Turning Point Therapeutics I | 0.4 | $624k | 8.0k | 78.00 | |
Pioneer Natural Resources | 0.4 | $618k | 3.8k | 162.63 | |
Tg Therapeutics (TGTX) | 0.3 | $582k | 15k | 38.80 | |
Aspira Womens Health | 0.3 | $579k | 103k | 5.62 | |
Apellis Pharmaceuticals (APLS) | 0.3 | $506k | 8.0k | 63.25 | |
Stoke Therapeutics (STOK) | 0.3 | $505k | 15k | 33.67 | |
Protagonist Therapeutics (PTGX) | 0.3 | $449k | 10k | 44.90 | |
Zentalis Pharmaceuticals (ZNTL) | 0.3 | $426k | 8.0k | 53.25 | |
Xencor (XNCR) | 0.3 | $424k | 12k | 34.47 | |
Laird Superfood (LSF) | 0.3 | $418k | 14k | 29.86 | |
Chemocentryx | 0.2 | $402k | 30k | 13.40 | |
Akebia Therapeutics (AKBA) | 0.2 | $379k | 100k | 3.79 | |
Dicerna Pharmaceuticals | 0.2 | $373k | 10k | 37.30 | |
Amicus Therapeutics (FOLD) | 0.2 | $366k | 38k | 9.63 | |
Sientra | 0.2 | $318k | 40k | 7.95 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $316k | 20k | 15.80 | |
Aziyo Biologics (ELUT) | 0.2 | $288k | 30k | 9.60 | |
Kiniksa Pharmaceuticals | 0.2 | $279k | 20k | 13.95 | |
Arcutis Biotherapeutics (ARQT) | 0.1 | $246k | 9.0k | 27.33 | |
Inflarx Nv (IFRX) | 0.1 | $208k | 70k | 2.97 | |
Cytokinetics (CYTK) | 0.1 | $198k | 10k | 19.80 | |
Hookipa Pharma Inc equity | 0.1 | $183k | 20k | 9.15 | |
Therapeuticsmd | 0.1 | $119k | 100k | 1.19 | |
Concert Pharmaceuticals I equity | 0.1 | $84k | 20k | 4.20 |